scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41569-018-0077-X |
P698 | PubMed publication ID | 30181596 |
P50 | author | Nadia Rosenthal | Q6957721 |
Elvira Forte | Q79579843 | ||
P2093 | author name string | Milena Bastos Furtado | |
P2860 | cites work | Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion | Q24297271 |
PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene Superfamily | Q24299656 | ||
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation | Q24316945 | ||
De novo cardiomyocytes from within the activated adult heart after injury | Q24605971 | ||
CD20 deficiency in humans results in impaired T cell-independent antibody responses | Q24653638 | ||
Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution | Q24679240 | ||
Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases | Q26767423 | ||
Exosomes Mediate the Intercellular Communication after Myocardial Infarction | Q26768620 | ||
View from the heart: cardiac fibroblasts in development, scarring and regeneration | Q26770160 | ||
Repair after myocardial infarction, between fantasy and reality: the role of chemokines | Q26825806 | ||
The dynamic role of cardiac fibroblasts in development and disease | Q26830787 | ||
Resolution of inflammation: an integrated view | Q26852569 | ||
Tissue-resident macrophages | Q26991488 | ||
New insights into the morphogenic role of stromal cells and their relevance for regenerative medicine. lessons from the heart | Q27001340 | ||
Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction | Q27006536 | ||
Immune modulation of stem cells and regeneration | Q27010686 | ||
Pericytes: developmental, physiological, and pathological perspectives, problems, and promises | Q27026645 | ||
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
Pericytes, an overlooked player in vascular pathobiology | Q28070053 | ||
Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. | Q35623089 | ||
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis | Q35679591 | ||
PDGFRα demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium | Q35775407 | ||
Micro- and Nanoparticles for Treating Cardiovascular Disease | Q35801354 | ||
Distinguishing Mast Cell Progenitors from Mature Mast Cells in Mice | Q35844427 | ||
The dynamics of fibroblast-myocyte-capillary interactions in the heart | Q35869237 | ||
Reparative inflammation takes charge of tissue regeneration | Q35899475 | ||
Structural and functional characterisation of cardiac fibroblasts | Q35994493 | ||
Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages | Q36021832 | ||
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family | Q28199597 | ||
Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy | Q28238421 | ||
Human natural killer cell receptors: insights into their molecular function and structure | Q28241698 | ||
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart | Q28264555 | ||
Using exosomes, naturally-equipped nanocarriers, for drug delivery | Q28265872 | ||
Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin | Q28294723 | ||
Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages | Q28306800 | ||
Genetic tools for identifying and manipulating fibroblasts in the mouse | Q28392538 | ||
Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses | Q28616569 | ||
DAMPs, PAMPs and alarmins: all we need to know about danger | Q29547535 | ||
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions | Q29615381 | ||
The M1 and M2 paradigm of macrophage activation: time for reassessment | Q29615845 | ||
Fate mapping analysis reveals that adult microglia derive from primitive macrophages | Q29616177 | ||
Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
Transient regenerative potential of the neonatal mouse heart | Q29620371 | ||
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice | Q29622850 | ||
Computational modeling of cardiac fibroblasts and fibrosis | Q30278019 | ||
Genetic networks governing heart development. | Q30367427 | ||
Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative Medicine | Q30390768 | ||
Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways | Q30424410 | ||
Proangiogenic scaffolds as functional templates for cardiac tissue engineering. | Q30496361 | ||
Bioengineering Human Myocardium on Native Extracellular Matrix. | Q30706278 | ||
Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation | Q33185127 | ||
Organization of fibroblasts in the heart | Q33204765 | ||
A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease | Q33390453 | ||
Porous polycaprolactone scaffold for cardiac tissue engineering fabricated by selective laser sintering | Q33520176 | ||
Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload | Q33559670 | ||
Revealing new mouse epicardial cell markers through transcriptomics | Q33623752 | ||
Characterization and expression of the murine CD3-epsilon gene | Q33671640 | ||
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction | Q33704093 | ||
Direct visualization of membrane architecture of myelinating cells in transgenic mice expressing membrane-anchored EGFP. | Q33718902 | ||
Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. | Q33780538 | ||
Macrophages and fibroblasts during inflammation and tissue repair in models of organ regeneration. | Q33793909 | ||
Age-related changes in tissue macrophages precede cardiac functional impairment | Q33801206 | ||
Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis | Q33808347 | ||
Cardiac-Restricted IGF-1Ea Overexpression Reduces the Early Accumulation of Inflammatory Myeloid Cells and Mediates Expression of Extracellular Matrix Remodelling Genes after Myocardial Infarction | Q36160819 | ||
CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation | Q36206168 | ||
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny | Q36263627 | ||
Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction | Q36349782 | ||
A dermal HOX transcriptional program regulates site-specific epidermal fate | Q36411154 | ||
Cardiac fibroblasts: friend or foe? | Q36450335 | ||
Systemic analysis of PPARγ in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity | Q36509966 | ||
The Living Scar--Cardiac Fibroblasts and the Injured Heart | Q36535178 | ||
Revisiting Cardiac Cellular Composition | Q36552350 | ||
Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure | Q36640570 | ||
Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132 | Q36757074 | ||
Exosomes and exosomal miRNAs in cardiovascular protection and repair. | Q36816939 | ||
Adult cardiac-resident MSC-like stem cells with a proepicardial origin | Q36838490 | ||
Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. | Q36870887 | ||
Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems | Q36885445 | ||
Heterotopic transplantation of a decellularized and recellularized whole porcine heart. | Q36966403 | ||
Translation and Clinical Development of Antithrombotic Aptamers | Q36987361 | ||
Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application | Q36998274 | ||
Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease | Q37033031 | ||
Cardiac Fibro-Adipocyte Progenitors Express Desmosome Proteins and Preferentially Differentiate to Adipocytes Upon Deletion of the Desmoplakin Gene. | Q37037380 | ||
Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease | Q37131569 | ||
Dendritic cell homeostasis | Q37157975 | ||
Fibroblast-myocyte coupling in the heart: Potential relevance for therapeutic interventions | Q37255246 | ||
IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. | Q37293969 | ||
Prevascularization of cardiac patch on the omentum improves its therapeutic outcome | Q37329635 | ||
Mesenchymal stem cells: the fibroblasts' new clothes? | Q37358415 | ||
Cardiac fibroblasts: at the heart of myocardial remodeling | Q37491524 | ||
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial | Q37494353 | ||
Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction | Q37544973 | ||
Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation | Q37581780 | ||
Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? | Q37635555 | ||
Noradrenergic neurons regulate monocyte trafficking and mortality during gram-negative peritonitis in mice | Q37680580 | ||
Fibroblasts in myocardial infarction: a role in inflammation and repair | Q37716851 | ||
Perivascular ancestors of adult multipotent stem cells | Q37746571 | ||
Immunomodulatory activity of mesenchymal stem cells. | Q37824486 | ||
Heart failure after myocardial infarction: clinical implications and treatment | Q37891910 | ||
Inflammation as an animal development phenomenon. | Q37949591 | ||
Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends? | Q38046798 | ||
Biologics and the cardiovascular system: a double-edged sword | Q38071328 | ||
Neutrophil roles in left ventricular remodeling following myocardial infarction. | Q38111517 | ||
Mesenchymal stromal cells: sensors and switchers of inflammation | Q38149359 | ||
The cholinergic anti-inflammatory pathway: a critical review | Q38177419 | ||
Exosomes and cardiac repair after myocardial infarction | Q38179329 | ||
Biomaterials in myocardial tissue engineering | Q38234469 | ||
Preparing the ground for tissue regeneration: from mechanism to therapy | Q38237617 | ||
Mesenchymal stem cell-like properties in fibroblasts | Q38244599 | ||
An overview of FDA-approved biologics medicines | Q38249104 | ||
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications | Q38261365 | ||
The biology of innate lymphoid cells | Q38319907 | ||
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial | Q38400558 | ||
Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs). | Q38626688 | ||
Multi-Cellular Transcriptional Analysis of Mammalian Heart Regeneration | Q38667300 | ||
The neonate versus adult mammalian immune system in cardiac repair and regeneration. | Q38708539 | ||
Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). | Q38801384 | ||
Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure | Q38814473 | ||
Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps | Q38863047 | ||
Bio-effect of nanoparticles in the cardiovascular system | Q38865230 | ||
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. | Q38875774 | ||
The cardiac fibroblast: Origin, identity and role in homeostasis and disease. | Q38898089 | ||
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins | Q38939435 | ||
Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: A vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies | Q38941121 | ||
Defining the Cardiac Fibroblast | Q38982080 | ||
Transcriptional Control of Cell Lineage Development in Epicardium-Derived Cells. | Q39007418 | ||
The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin' Away | Q39095681 | ||
Characteristics and Roles of Exosomes in Cardiovascular Disease | Q39098698 | ||
The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial-Mesenchymal Barrier | Q39106724 | ||
Cardiomyopathy - An approach to the autoimmune background | Q39120664 | ||
Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair | Q33850239 | ||
Genetic lineage tracing defines myofibroblast origin and function in the injured heart | Q33908363 | ||
Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature | Q34007272 | ||
Expression of the familial cardiac valvular dystrophy gene, filamin-A, during heart morphogenesis. | Q34018376 | ||
Neutrophil kinetics in health and disease. | Q34092240 | ||
Tissue engineering of a differentiated cardiac muscle construct | Q34113271 | ||
The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. | Q34173371 | ||
Sorting out where fibroblasts come from. | Q34251249 | ||
Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells | Q34261674 | ||
Mesenchymal stromal cells and fibroblasts: a case of mistaken identity? | Q34264374 | ||
The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. | Q34273888 | ||
Inflammatory cytokines and postmyocardial infarction remodeling | Q34329136 | ||
Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. | Q34351310 | ||
Progressive replacement of embryo-derived cardiac macrophages with age | Q34375144 | ||
Environment drives selection and function of enhancers controlling tissue-specific macrophage identities | Q34452301 | ||
The inflammatory response in myocardial infarction | Q34463456 | ||
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts | Q34508414 | ||
Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart | Q34526107 | ||
Chasing the recipe for a pro-regenerative immune system | Q34537287 | ||
Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis | Q34646876 | ||
Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes | Q34650719 | ||
Abandoning M1/M2 for a Network Model of Macrophage Function | Q34677978 | ||
Pervasive roles of microRNAs in cardiovascular biology | Q34775686 | ||
Adult mouse epicardium modulates myocardial injury by secreting paracrine factors | Q34875955 | ||
Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. | Q34899171 | ||
Transplantation of a tissue-engineered human vascularized cardiac muscle | Q34994775 | ||
A systematic analysis of neonatal mouse heart regeneration after apical resection | Q34995884 | ||
Decreased myocardial dendritic cells is associated with impaired reparative fibrosis and development of cardiac rupture after myocardial infarction in humans. | Q35021896 | ||
ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model | Q35126632 | ||
Developmental patterns and characteristics of epicardial cell markers Tbx18 and Wt1 in murine embryonic heart | Q35241220 | ||
A cell-penetrating phospholamban-specific RNA aptamer enhances Ca2+ transients and contractile function in cardiomyocytes | Q35266526 | ||
Nanoparticles targeting the infarcted heart | Q35332320 | ||
The inflammatory response in myocardial injury, repair, and remodelling. | Q35529656 | ||
Development of cardiac parasympathetic neurons, glial cells, and regional cholinergic innervation of the mouse heart | Q48450219 | ||
Franklin H. Epstein Lecture. Cardiac development and implications for heart disease | Q48542223 | ||
Metchnikoff and the phagocytosis theory | Q48678873 | ||
Single-Cell Sequencing of the Healthy and Diseased Heart Reveals Ckap4 as a New Modulator of Fibroblasts Activation | Q49546461 | ||
Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity | Q49871522 | ||
Single-Cell Transcriptional Profiling Reveals Cellular Diversity and Intercommunication in the Mouse Heart. | Q49963197 | ||
Tissue regeneration: The crosstalk between mesenchymal stem cells and immune response | Q49994137 | ||
Infarct Fibroblasts Do Not Derive From Bone Marrow Lineages | Q50161876 | ||
Resident and Monocyte-Derived Macrophages in Cardiovascular Disease | Q50187351 | ||
Resident fibroblast expansion during cardiac growth and remodeling. | Q50204070 | ||
Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. | Q50503050 | ||
Cardiac endothelial cells express Wilms' tumor-1: Wt1 expression in the developing, adult and infarcted heart. | Q50601069 | ||
Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes. | Q50658902 | ||
The extracellular matrix protein agrin promotes heart regeneration in mice. | Q50852735 | ||
Heart Regeneration 4.0: Matrix Medicine. | Q50897035 | ||
Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction. | Q51001645 | ||
Macrophages Facilitate Electrical Conduction in the Heart. | Q51041551 | ||
Neutralization of pathogenic beta1-receptor autoantibodies by aptamers in vivo: the first successful proof of principle in spontaneously hypertensive rats. | Q51740847 | ||
Properties and Immune Function of Cardiac Fibroblasts. | Q51835859 | ||
Mechanosensitive fibroblasts in the sino-atrial node region of rat heart: interaction with cardiomyocytes and possible role. | Q52367083 | ||
Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. | Q52583529 | ||
Immune Modulation in Heart Failure: the Promise of Novel Biologics. | Q52654858 | ||
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration. | Q52729011 | ||
The adaptive immune response to cardiac injury-the true roadblock to effective regenerative therapies? | Q52729626 | ||
Myocardial Polyploidization Creates a Barrier to Heart Regeneration in Zebrafish. | Q52730089 | ||
Interleukin-1alpha stimulates proinflammatory cytokine expression in human cardiac myofibroblasts. | Q52849175 | ||
Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. | Q52853439 | ||
Acellular human heart matrix: A critical step toward whole heart grafts. | Q53226040 | ||
Cardiac fibroblasts support cardiac inflammation in heart failure. | Q54196284 | ||
Evolution, comparative biology and ontogeny of vertebrate heart regeneration. | Q55013256 | ||
The local microenvironment limits the regenerative potential of the mouse neonatal heart. | Q55279807 | ||
Heart regeneration in the salamander relies on macrophage-mediated control of fibroblast activation and the extracellular landscape. | Q55403246 | ||
Mesenchymal stem cells can be obtained from the human saphena vein | Q56787029 | ||
Aptamer therapy for heart failure? | Q58843654 | ||
Interstitial dendritic cells of the rat heart. Quantitative and ultrastructural changes in experimental myocardial infarction | Q70586866 | ||
Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury | Q83333586 | ||
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR | Q83398624 | ||
Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice | Q83567632 | ||
Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function | Q84080152 | ||
Evaluation of a peritoneal-generated cardiac patch in a rat model of heterotopic heart transplantation | Q84134042 | ||
Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy | Q84494711 | ||
Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization | Q88072773 | ||
"Fibroblast" pharmacotherapy - Advancing the next generation of therapeutics for clinical cardiology | Q89149655 | ||
Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis. | Q39170625 | ||
Redefining the identity of cardiac fibroblasts. | Q39258331 | ||
Cardiac fibroblasts: more than mechanical support | Q39265518 | ||
Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues | Q39791944 | ||
Sca-1+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury | Q40244758 | ||
Collagen phagocytosis by fibroblasts is regulated by decorin | Q40438617 | ||
Review of the macrophage disappearance reaction. | Q40608826 | ||
Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. | Q41021385 | ||
HMGB1 Neutralizing Antibody Attenuates Cardiac Injury and Apoptosis Induced by Hemorrhagic Shock/Resuscitation in Rats | Q41186895 | ||
Role of dendritic cells in cardiovascular diseases | Q41332123 | ||
Primitive Embryonic Macrophages are Required for Coronary Development and Maturation | Q41493808 | ||
Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System | Q41595928 | ||
Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable | Q41699059 | ||
Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction | Q41769718 | ||
Macrophages are required for neonatal heart regeneration | Q41985583 | ||
Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations | Q42114294 | ||
NK cell compartment in patients with coronary heart disease | Q42772357 | ||
Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation | Q42775274 | ||
Tissue-resident Sca1+ PDGFRα+ mesenchymal progenitors are the cellular source of fibrofatty infiltration in arrhythmogenic cardiomyopathy | Q42957210 | ||
Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling | Q43152071 | ||
Regulatory T cells ameliorate cardiac remodeling after myocardial infarction | Q43997915 | ||
Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. | Q44135784 | ||
Biomimetic poly(glycerol sebacate) (PGS) membranes for cardiac patch application | Q44188072 | ||
Inducible site-specific recombination in myelinating cells | Q44248492 | ||
Upregulation of endothelial adhesion molecules in hearts with congestive and ischemic cardiomyopathy: immunohistochemical evaluation of inflammatory endothelial cell activation | Q45203788 | ||
Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium | Q45206400 | ||
Connective tissue cells, but not muscle cells, are involved in establishing the proximo-distal outcome of limb regeneration in the axolotl | Q45224409 | ||
ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction | Q45298946 | ||
Cardiac Fibroblasts Adopt Osteogenic Fates and Can Be Targeted to Attenuate Pathological Heart Calcification. | Q45932492 | ||
Zebrafish Regulatory T Cells Mediate Organ-Specific Regenerative Programs. | Q47282781 | ||
Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin E1. | Q47324581 | ||
Expression of smooth muscle myosin heavy chain B in cardiac vessels of normotensive and hypertensive rats | Q47756276 | ||
The murine homologue of the T lymphocyte CD2 antigen: molecular cloning, chromosome assignment and cell surface expression | Q48342714 | ||
P433 | issue | 10 | |
P304 | page(s) | 601-616 | |
P577 | publication date | 2018-10-01 | |
P1433 | published in | Nature Reviews Cardiology | Q2108444 |
P1476 | title | The interstitium in cardiac repair: role of the immune-stromal cell interplay | |
P478 | volume | 15 |
Q91291231 | Cardiac repair and the putative role of stem cells |
Q92813722 | Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding |
Q90044692 | Dynamic Interstitial Cell Response during Myocardial Infarction Predicts Resilience to Rupture in Genetically Diverse Mice |
Q91874691 | Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity |
Q64284711 | Inhibitor of DNA binding in heart development and cardiovascular diseases |
Q93165013 | Leukocyte-Dependent Regulation of Cardiac Fibrosis |
Q89748173 | Macrophages produce collagen for myocardial scar formation |
Q58111146 | Many Cells Make Life Work-Multicellularity in Stem Cell-Based Cardiac Disease Modelling |
Q64059811 | Modulation of TNFα Activity by the microRNA Let-7 Coordinates Zebrafish Heart Regeneration |
Q64085849 | On Zebrafish Disease Models and Matters of the Heart |
Q101166744 | Resident macrophages keep mitochondria running in the heart |
Q59128840 | Therapeutic approaches for cardiac regeneration and repair |
Q64084317 | Three in a Box: Understanding Cardiomyocyte, Fibroblast, and Innate Immune Cell Interactions to Orchestrate Cardiac Repair Processes |
Q64065124 | Toward Regeneration of the Heart: Bioengineering Strategies for Immunomodulation |
Search more.